amobarbital has been researched along with Remission, Spontaneous in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ward, NG | 1 |
| Rowlett, DB | 1 |
| Burke, P | 1 |
| Cawley, RH | 1 |
| Post, F | 1 |
| Whitehead, A | 1 |
2 other studies available for amobarbital and Remission, Spontaneous
| Article | Year |
|---|---|
Sodium amylobarbitone in the differential diagnosis of confusion.
Topics: Acute Disease; Adult; Amobarbital; Cognition Disorders; Confusion; Diagnosis, Differential; Female; | 1978 |
Barbiturate tolerance and psychological functioning in elderly depressed patients.
Topics: Adult; Aged; Amitriptyline; Amobarbital; Arousal; Cognition; Depression; Drug Tolerance; Electroconv | 1973 |